• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型侵袭性甲状腺癌患者预后的预测因素

Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.

作者信息

Marchesi Maurizio, Biffoni Marco, Biancari Fausto, Berni Alberto, Campana Francesco Paolo

机构信息

Division of General Surgery, Department of Surgical Sciences, University "La Sapienza", Rome, Italy.

出版信息

Eur J Surg Suppl. 2003 Jul(588):46-50.

PMID:15200043
Abstract

OBJECTIVE

To identify the risk factors affecting the outcome of operations for differentiated and aggressive thyroid carcinoma which may indicate the need for a more aggressive surgical treatment.

DESIGN

Retrospective study.

SETTING

University hospital.

PATIENTS AND INTERVENTIONS

143 patients underwent total thyroidectomy with or without central neck lymphadenectomy or modified neck dissection. There were 85 papillary, 34 follicular, 6 widely-invasive follicular, 6 insular, five oxyphilic, five tall cell, and two diffuse sclerosing papillary carcinomas.

MAIN OUTCOME MEASURE

Disease-related survival.

RESULTS

At 12-years, the survival was 96%, being 98% among patients with differentiated and 83% among those with aggressive carcinoma (p = 0.0006). Insular and oxyphilic carcinomas had the worst prognosis (at 10 years, 67% and 60%, respectively, p < 0.0001). The high-risk age, metastases, and extent score (AMES) group had worse survival than the low-risk group (12 years, 84% compared with 98%, p = 0.001). Among patients with differentiated carcinoma, the low-risk AMES group had also better outcome than those in the high-risk AMES group (at 12 years, 100% compared with 86%, p < 0.0001), but there was no such difference among patients with aggressive disease. Multivariate analysis showed that women (RR 14.28, 95% confidence interval (CI) 1.13 to 180.28), patients with tumours > or = 5 cm in size (RR 9.60, 95%CI 1.01 to 91.43) and AMES high-risk patients (RR 30.17, 95% CI 1.57 to 577.48) had the worst outcome.

CONCLUSION

In patients with differentiated thyroid carcinoma, total thyroidectomy and, if the AMES score indicates a high risk, central neck lymphadenectomy with or without modified neck dissection, is associated with a favourable outcome. Poorer outcome is expected if the carcinoma is aggressive, and an aggressive surgical approach is advocated as a routine.

摘要

目的

确定影响分化型和侵袭性甲状腺癌手术预后的危险因素,这些因素可能提示需要采取更积极的手术治疗。

设计

回顾性研究。

地点

大学医院。

患者与干预措施

143例患者接受了全甲状腺切除术,伴或不伴中央区颈部淋巴结清扫术或改良颈部淋巴结清扫术。其中有85例乳头状癌、34例滤泡状癌、6例广泛侵袭性滤泡状癌、6例岛状癌、5例嗜酸性细胞癌、5例高细胞癌和2例弥漫性硬化性乳头状癌。

主要观察指标

疾病相关生存率。

结果

12年时,生存率为96%,分化型癌患者中为98%,侵袭性癌患者中为83%(p = 0.0006)。岛状癌和嗜酸性细胞癌预后最差(10年时,分别为67%和60%,p < 0.0001)。高风险年龄、转移和范围评分(AMES)组的生存率低于低风险组(12年时,分别为84%和98%,p = 0.001)。在分化型癌患者中,低风险AMES组的预后也优于高风险AMES组(12年时,分别为100%和86%,p < 0.0001),但在侵袭性疾病患者中无此差异。多因素分析显示,女性(风险比[RR]为14.28,95%置信区间[CI]为1.13至180.28)、肿瘤大小≥5 cm的患者(RR为9.60,95%CI为1.01至91.43)和AMES高风险患者(RR为30.17,95%CI为1.57至577.48)预后最差。

结论

对于分化型甲状腺癌患者,全甲状腺切除术,如果AMES评分显示高风险,则行中央区颈部淋巴结清扫术,伴或不伴改良颈部淋巴结清扫术,预后良好。如果癌具有侵袭性,则预后较差,提倡常规采取积极的手术方式。

相似文献

1
Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.分化型侵袭性甲状腺癌患者预后的预测因素
Eur J Surg Suppl. 2003 Jul(588):46-50.
2
Predicting outcome and directing therapy for papillary thyroid carcinoma.预测甲状腺乳头状癌的预后并指导治疗
Arch Surg. 2004 Apr;139(4):390-4; discussion 393-4. doi: 10.1001/archsurg.139.4.390.
3
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
4
Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.分化型甲状腺癌:21岁以下出现远处转移患者的临床特征、治疗及预后。儿童癌症集团外科学科委员会的报告。
J Pediatr Surg. 2000 Jun;35(6):955-9; discussion 960. doi: 10.1053/jpsu.2000.6935.
5
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.美国分化型甲状腺癌的AMES预后指数与甲状腺切除范围
Surgery. 2004 Sep;136(3):609-16. doi: 10.1016/j.surg.2003.12.009.
6
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.具有小梁状、岛状和实性结构的甲状腺低分化癌:183例患者的临床病理研究
Cancer. 2004 Mar 1;100(5):950-7. doi: 10.1002/cncr.20087.
7
Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.碘充足的地方性甲状腺肿地区的滤泡性甲状腺癌:一项前瞻性收集、回顾性分析的临床试验。
Ann Surg. 2009 Jun;249(6):1023-31. doi: 10.1097/SLA.0b013e3181a77b7b.
8
Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.基于高分化甲状腺癌风险分类的选择性手术及辅助治疗。
J Surg Oncol. 2006 Dec 15;94(8):678-82. doi: 10.1002/jso.20698.
9
Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.预后因素及风险分组在分化型甲状腺癌管理中的意义
Laryngoscope. 2004 Mar;114(3):393-402. doi: 10.1097/00005537-200403000-00001.
10
[Lymphadenectomy in the differentiated thyroid carcinoma].[分化型甲状腺癌的淋巴结清扫术]
Ann Ital Chir. 2004 May-Jun;75(3):299-303.

引用本文的文献

1
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence.低危型甲状腺乳头状癌的管理:日本独特的常规策略及其提高证据水平的努力。
Surg Today. 2010 Mar;40(3):199-215. doi: 10.1007/s00595-009-4034-5. Epub 2010 Feb 24.
2
Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.滤泡性甲状腺癌侧颈淋巴结受累的危险因素。
World J Surg. 2008 Dec;32(12):2623-6. doi: 10.1007/s00268-008-9742-2.
3
Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines.
转酮醇酶样1是分化型甲状腺癌的治疗靶点吗?一项关于甲状腺癌细胞系的研究。
Invest New Drugs. 2009 Aug;27(4):297-303. doi: 10.1007/s10637-008-9174-8. Epub 2008 Sep 20.
4
Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.基于术前超声检查的甲状腺乳头状癌选择性淋巴结清扫的前瞻性结果
World J Surg. 2008 Nov;32(11):2494-502. doi: 10.1007/s00268-008-9711-9.
5
Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.术前及术中发现引导下的分化型甲状腺癌侧方淋巴结清扫术
World J Surg. 2008 May;32(5):729-39. doi: 10.1007/s00268-007-9315-9.
6
Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.分化型甲状腺癌的侧方及纵隔淋巴结清扫:适应证、益处及风险
World J Surg. 2007 May;31(5):905-15. doi: 10.1007/s00268-006-0722-0.
7
Overview of the management of differentiated thyroid cancer.分化型甲状腺癌的管理概述。
Curr Treat Options Oncol. 2005 Jan;6(1):47-57. doi: 10.1007/s11864-005-0012-3.